Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
A study published in the Journal of the American Medical Association found that people with type 2 diabetes who take semaglutide drugs like Rybelsus are twice as likely to develop a type of vision loss caused by NAION (nonarteritic anterior ischemic optic neuropathy)
What underpins progression at the tissue, cellular and molecular levels is still unknown, but taken together, emerging data strongly point to an underlying chronic cytodegenerative process starting early and operating largely independently of overt inflammation
Moreover, Gao et al
S.GreenwayF
The initial study results add to a long list of potential health benefits of the treatment, known as tirzepatide, besides helping patients shed significant pounds and regulate blood sugar under the drug's brand names, Zepbound and Mounjaro, respectively
US$ 27.48
US$ 29.15
US$ 25.64
US$ 20.08
US$ 21.16
